TOPIX 500
2.898,75
PKT
+70,35
PKT
+2,49
%
Werbung
Analysen zu TOPIX 500-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 23.08.05 | Astellas Pharma underperform | Wachovia Sec | |
| 23.08.05 | Astellas Pharma overweight | Morgan Stanley | |
| 17.08.05 | Rohm halten | Asia Investor | |
| 16.08.05 | Astellas Pharma neutral | Credit Suisse First Boston | |
| 15.08.05 | Astellas Pharma Neutral | Credit Suisse First Boston | |
| 10.08.05 | Bridgestone equal-weight | Morgan Stanley | |
| 03.08.05 | Honda Motor kaufen | Asia Investor | |
| 29.07.05 | Astellas Pharma neutral | Sun Trust Robinson Humphrey | |
| 28.07.05 | Honda Motor overweight | Morgan Stanley | |
| 29.07.05 | Honda Motor overweight | Prudential Financial | |
| 21.07.05 | HOYA kaufen | Frankfurter Tagesdienst | |
| 20.07.05 | Honda Motor overweight | Morgan Stanley | |
| 08.07.05 | Astellas Pharma buy | Banc of America Sec. | |
| 11.07.05 | Honda Motor overweight | Prudential Financial | |
| 06.07.05 | Honda Motor overweight | Morgan Stanley | |
| 29.06.05 | Astellas Pharma underweight | JP Morgan | |
| 29.06.05 | Astellas Pharma Underweight | JP Morgan | |
| 23.06.05 | Astellas Pharma | Der Aktionär | |
| 30.06.05 | Astellas Pharma | Der Aktionär | |
| 23.06.05 | Astellas Pharma | Der Aktionär | |
| 20.06.05 | Bridgestone equal-weight | Morgan Stanley | |
| 15.06.05 | Bridgestone equal-weight | Morgan Stanley | |
| 08.06.05 | Mitsubishi kaufen | Asia Investor | |
| 08.06.05 | RICOH Underweight | Lehman Brothers | |
| 27.05.05 | Honda Motor overweight | Morgan Stanley | |
| 06.04.05 | Astellas Pharma Market Perform | Wachovia Sec | |
| 23.03.05 | Showa Denko K.K. In-Line | Goldman Sachs | |
| 15.03.05 | Astellas Pharma Equal weight | Lehman Brothers | |
| 22.02.05 | NEC Buy | Smith Barney Citigroup | |
| 09.02.05 | Astellas Pharma Neutral | First Albany | |
| 28.01.05 | Honda Motor Outperform | Credit Suisse First Boston | |
| 13.01.05 | Renesas Electronics Overweight | Morgan Stanley | |
| 11.01.05 | Honda Motor Outperform | Goldman Sachs | |
| 07.01.05 | Astellas Pharma Neutral | UBS |